Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 23.65 | N/A |
| PEG Ratio (TTM) | -0.41 | N/A |
| P/S Ratio (TTM) | 0.59 | N/A |
| P/B Ratio (TTM) | 0.98 | N/A |
| P/FCF Ratio (TTM) | 11.17 | N/A |
| Price to 5YR AVG Earnings Ratio | 25.88 | N/A |
| Price to 5YR AVG FCF Ratio | 21.34 | N/A |
Profitability (28%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.30% | N/A |
| ROE (TTM) | 4.18% | N/A |
| Net Profit Margin (TTM) | 2.49% | N/A |
| ROIC 5YR AVG | 0.69% | N/A |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1.77% | 98.86% | 62.40% |
| Revenue | 2.85% | -4.72% | 2.21% |
| Net Income | -1.77% | 101.47% | 64.44% |
| Cash Flow | -668.22% | 95.50% | 99.33% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.83 | N/A |
| Quick Ratio (TTM) | 0.77 | N/A |
| D/E Ratio (TTM) | 0.31 | N/A |
| Interest Coverage (TTM) | 2.40 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.62 | N/A |
| LTL to 5YR AVG FCF | 2.47 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.51% | N/A |